Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 10913712 Tetracycline compounds

Patent 10913712 was granted and assigned to Tetraphase Pharmaceuticals on February, 2021 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Tetraphase Pharmaceuticals

Current Assignee

Tetraphase Pharmaceuticals

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

10913712

Patent Inventor Names

Xiao-Yi Xiao0

Minsheng He0

Roger B. Clark0

Wu-Yan Zhang0

Cuixiang Sun0

Diana Katharine Hunt0

Magnus P. Ronn0

Date of Patent

February 9, 2021

Patent Application Number

16393725

Date Filed

April 24, 2019

Patent Citations

‌

US Patent 10072007 Tetracycline compounds

‌

US Patent 10315992 Tetracyline compounds

Patent Citations Received

‌

US Patent 11578044 Crystalline forms of eravacycline

Patent Primary Examiner

‌

Amanda L. Aguirre

Patent abstract

The present invention is directed to a compound represented by Structural Formula (I):

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10913712 Tetracycline compounds

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API